TrialCancer2009

Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.

Domingo G Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.